Galera Therapeutics, Inc. (GRTX.D)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $16.28
- As of
Kresmion compiles this page from GRTX.D's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Galera Therapeutics, Inc. (GRTX.D): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-04.
See the full GRTX.D dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GRTX.D on one page. Preview it with sample data, then open it live with a free account.
Preview the GRTX.D dossierActive signals for GRTX.D
No recent signals on GRTX.D in the last 180 days.
FREE, NO ACCOUNT
Every signal on GRTX.D, as it fires
New filings, 13F moves and cross asset signals on GRTX.D land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, GRTX.D
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GRTX.D against its peers
GRTX.D's return on equity of 3750.6% ranks in the 98th percentile of 24 Biotechnology sub-industry peers, fiscal periods ending between 2025-11-30 and 2025-12-31.
| Metric | GRTX.D | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 77.4M | n/a | 18 |
| Gross margin | n/a | 70.1% | n/a | 7 |
| Operating margin | n/a | -125.6% | n/a | 16 |
| Net margin | n/a | -107.4% | n/a | 16 |
| Return on equity | 3750.6% | -29.7% | 98 | 24 |
Peers (24): XENE, VKTX, ACAD, IDYA, CELC, TLX, LEGN, VCYT, RLAY, IRON, CPRX.D, DNLI, TNGX, ARQT, NRIX, DYN, ELVN, ZLAB, EWTX, ATAI.D, DNTH, MBX, VRDN, NAMS. Left out: PBLS (no annual filing). Fiscal periods ending between 2025-11-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (GRTX.D: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow GRTX.D on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to GRTX.D for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.